Featured Products & Services

1. Automated Vision Inspection Systems For Injectable Drug Products: Vials, Syringes, Cartridges, Bottles 2/2/2022

   We offer a comprehensive range of automatic inspection machines for injectable pharmaceutical products contained in ampoules, vials, cartridges, syringes and bottles. Designed and manufactured to meet the most demanding technical requirements, our solutions feature different production speeds and advanced vision standards for an optimum performance.

2. Rapid Development Through Phase I CTM 1/28/2022

   Ascendia works with discovery-stage pharmaceutical companies to provide lab-scale formulations suitable for pre-clinical testing. We conduct pre-formulation assessments, bioavailability modeling, and formulation approach comparisons. We provide trial formulations suitable for animal studies, toxicology studies, and cGMP clinical trial materials for Phase I studies.

3. Nasal Dosage Form Development 10/23/2024

   Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.

4. Robotic Multi-Format Filling & Closing System 1/2/2020

   AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

5. Small, Simple-To-Use Package For Delivering High-Viscosity Formulations 11/7/2025

   Subcutaneous

   Low - Medium Viscosities
   < 100 cP
   1 - 10 ml

   High - Ultra-High Viscosities
   >100 - 10,000 cP
   0.5 - 3 ml

   ArQ^® - Bios offers a small, simple to use package to deliver high viscosity formulations. Oval’s proprietary COC PDC technology allows us to build the device around a stronger drug container that can deliver 1ml of formulations up to 1000cP through a 25G needle in  less than 5 seconds. The ArQ-Bios  platform  also can deliver  greater volumes than 1 ml subject to matching  the formulation characteristics with acceptable patient tolerability.

6. Injection Molding 8/24/2020

   Capabilities that improve efficiency and accelerate development.

   B. Braun's OEM Division offers a variety of in-house molding capabilities including injection molding, insert molding and over molding. They own a primary 400,000-square-foot U.S. plant that includes a 16,500-square-foot ISO Class 8 molding facility housing some of B. Braun’s 80 injection molding presses, which range from 55-330 tons.

7. Concept Development and DFM

   A Blueprint for Success

   West believes that getting involved in the very early phases of product development enables the West team of experts to optimize your product design.  This philosophy has proven to yield significant short-term and long-term benefits.  Getting involved early improves cycle times, identifies the right materials for your specific application, lowers scrap, lowers capital costs and lowers long-term maintenance costs.  

8. cGMP Aseptic Manufacturing And Sterile Fill-Finish 1/28/2022

   Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.

9. Pharmaceutical Sterile Filling Systems For Eye Drops And Ophthalmic Products 8/3/2020

   Filling and capping machine for eye-drop bottles.

10. Isolator Barrier Pharmaceutical Aseptic Filling Systems 11/12/2020

    ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.